Experiment name | Clinical attributes |
Chen02_HCC_HBV_SF17 | Hepatocellular carcinoma (Liver cancer), Adenocarcinoma (Liver cancer), Cancer and cell line (Liver cancer), Cancer (Liver cancer), Hepatitis infected liver (Liver cancer*), Liver tissue (Liver cancer*), Liver tissue, cancer or cell line (Liver cancer*) |
Cuadras02_Infection_4_RRVa_1h_vs_mocka_1h |
Cuadras02_Infection_6_RRVb_1h_vs_mocka_1h |
Perou00_BC206B_AF | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), After doxorubicin chemotherapy (Breast cancer), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*) |
Sorlie01_BC1369 | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Dead prognosis (Breast cancer), Grade 3 (Breast cancer), Breast cancer - (prognostic) relapse (Breast cancer) |
Sorlie01_BC40 | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer) |
Whitfield02_34h_Thy_Noc_Exp4 | Cell line (HeLa cell cycle*), Epithelial cell line (HeLa cell cycle*), HeLa cell line (HeLa cell cycle*), Cancer and cell line (HeLa cell cycle*), M phase (HeLa cell cycle) |
Whitfield02_36h_Thy_Noc_Exp4 | Cell line (HeLa cell cycle*), Epithelial cell line (HeLa cell cycle*), HeLa cell line (HeLa cell cycle*), Cancer and cell line (HeLa cell cycle*) |